GX-P10

N/A

Report date: 2024/07/02 11:22:32

Base Information

Drug NameGX-P10
Drug Alias NameGX-P10
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 10 receptor agonistsProgrammed death-ligand 1 agonists
TargetsProgrammed death-ligand 1Interleukin 10 receptor
Therapy Area/IndicationsRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGannex Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A